Abstract:Background: Irritable bowel syndrome (IBS) is a functional bowel disorder which is characterized by abdominal pain and disturbed bowel habits. The pathophysiological mechanism is complex and still remains incompletely clear. Alterations at both the central and the peripheral level are thought to contribute to the symptoms of IBS, including psychosocial factors, visceral hypersensitivity and abnormal gastrointestinal motility and secretion. Several gut peptides contribute to the regulation of gastrointestinal function, but little is known about gut hormone secretion in IBS. Methods: We evaluated the concentrations of cholecystokinin (CCK), vasoactive intestinal peptide (VIP), somatostatin, substance P, neuropeptide Y (NPY) in plasma and in sigmoid tissue in 40 patients with IBS and 15 age- and gender-matched controls by using radioimmunoassay. Results: IBS patients had higher plasma level of CCK (p < 0.01), and the level of CCK in the sigmoid was also increased compared with controls (p < 0.05). The levels of somatostatin and substance P in fasting plasma and in the sigmoid were not different between IBS patients and control subjects (p > 0.05), but the levels of VIP in sigmoid tissue or in plasma were higher in IBS patients than in control group (p < 0.01). The NPY levels in both plasma and the sigmoid were significantly lower in IBS patients than in controls (p < 0.05). Plasma NPY level in patients with IBS with diarrhea as a predominant bowel pattern was lower than in patients with IBS with constipation as a predominant bowel pattern. Conclusion: IBS patients have increased levels of CCK and VIP and decreased NPY levels in fasting plasma and sigmoid tissue. These alterations of VIP, CCK and NPY may play a role in the pathogenesis of IBS.

Research Progress about Irritable Bowel Syndrome and Gastrointestinal Hormone in Traditional Chinese and Western Medicine

Research Progress of Integrated Traditional Chinese and Western Medicine for Diarrhea-Predominant Irritable Bowel Syndrome

Analysis of the status of intestinal microecology and irritable bowel syndrome

Irritable bowel syndrome etiology and pathogenesis of Progress

The research advances in the pathogenesis of irritable bowel syndrome

Pathophysiologic Findings of Irritable Bowel Syndrome in China.

A review of the irritable bowel syndrome investigation on epidemiology, pathogenesis and pathophysiology in China.

Research progress of the relationship of gut microbiota, gut-brain axis with irritable bowel syndrome

Survey of the experimental study of irritable bowel syndrome with TCM therapy

Current Research Status of Traditional Chinese Medicine External Treatment for Diarrhea Type Irritable Bowel Syndrome

Irritable bowel syndrome in China: a review on the epidemiology, diagnosis, and management

Progress in Traditional Chinese Medicine Research on the Treatment of IBS-D Due to Liver Depression and Spleen Deficiency with Classic Prescriptions

Advances in Study on Brain-gut Axis Dysfunction in Pathogenesis of Irritable Bowel Syndrome

Advances in Study on Intestinal Flora Disorder and Irritable Bowel Syndrome

New Insights into the Irritable Bowel Syndrome

Progress in the new drugs for the treatment of irritable bowel syndrome

Research of diarrhea-predominant irritable bowel syndrome liver spleen deficiency

The Advances on the Pathogenic Factor and Pathogenesis of Irritable Bowel Syndrome

Gut Microbiota and Irritable Bowel Syndrome: Status and Prospect

Research Progress of Dietary Intervention Strategies for Irritable Bowel Syndrome

Correlation of gut hormones with irritable bowel syndrome